MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    The development of a screening tool to identify movement disorders in patients with inborn errors of metabolism

    L. Koens, M. Klamer, D. Sival, B. Balint, K. Bhatia, M. Contarino, M. van Egmond, R. Erro, J. Friedman, V. Fung, C. Ganos, M. Kurian, A. Lang, E. Mcgovern, E. Roze, T. de Koning, M. Tijssen (Groningen, Netherlands)

    Objective: To develop a user-friendly rapid screening tool for non-movement disorder specialists to detect movement disorders in patients with inborn errors of metabolism. Background: Movement…
  • 2022 International Congress

    Psychiatric evaluation according to Brief Psychiatric Rating Scale-Expanded in patients with Parkinson’s disease

    N. Ben Ali, M. Ben Mahmoud, E. Derbel, H. Jamoussi, S. Fray, M. Fredj (Tunis, Tunisia)

    Objective: The aim of the study was to evaluate psychiatric manifestations of Parkinson’s disease (PD) and to establish statistical links with sociodemographic and clinical PD…
  • 2022 International Congress

    Parkinson’s Disease and Psychosocial Impact: Anxiety, Depression and Positive Symptoms

    O. Kaczmarek, S. Baek, A. Sethi, A. Stolarczyk, B. Bumstead, B. Anand, M. Buhse, M. Zarif, M. Gudesblatt (Patchogue, USA)

    Objective: Explore the relationship between patient self-reported assessment of positive symptoms, depression, and anxiety in PwPD. Background: Parkinson’s disease (PD) is a complex neurodegenerative disorder…
  • 2022 International Congress

    Improving the patient self-awareness of the first motor fluctuations in early Parkinson’s disease with a wearable sensor

    N. Caballol, A. Pérez-Soriano, A. Planas-Ballvé, A. ávila, P. Quispe, A. Bayés (Sant Joan Despí, Spain)

    Objective: We aim to assess if the use of a wearable sensor can increase the patient and caregiver self-awareness of the first motor fluctuations (MF).…
  • 2022 International Congress

    The benefit of exclusive nocturnal administration of a levodopa-carbidopa intestinal infusion for severe refractory sleep behavior disorder in Parkinson’s disease

    M. Rivera Sánchez, A. Sánchez Rodríguez, M. Sierra, I. González-Aramburu, MV. Sánchez Peláez, M. Martínez, J. Infante (Santander, Spain)

    Objective: Treatment by continuous diurnal intestinal infusion of levodopa is effective in improving sleep quality in Parkinson's disease (PD), but its use exclusively at night…
  • 2022 International Congress

    Resting heart rate variability in Parkinson’s disease with and without freezing of gait

    M. Falla, M. Masé, A. Randi, G. Strapazzon (Rovereto

    Objective: The aim of the study was to investigate heart rate variability (HRV) in Parkinson’s disease (PD) patients with and without freezing of gait (FOG). Background: FOG and…
  • 2022 International Congress

    Sweetspot analysis of Deep Brain Stimulation in Parkinson´s disease: Beyond the subthalamic nucleus?

    J. Garcia-Cornet, B. Pascual-Sedano, A. Campolongo, JA. Aibar-Duran, R. Rodriguez-Rodriguez, J. Kulisevsky, I. Aracil-Bolaños (Barcelona, Spain)

    Objective: To study the relationships between clinical response and leads location -in a cohort of Parkinson’s disease (PD) patients and deep brain stimulation of subthalamic…
  • 2022 International Congress

    A randomized, sham-controlled, crossover trial on Transcranial pulsed current stimulation (tPCS) in Huntington disease

    M. Tuesta Bernaola, Y. Tamilselvam, Y. Mahdi, J. Ganguly, D. Aur, M. Jog (London, Canada)

    Objective: 1. To assess brain network level dysfunction of Huntington disease (HD). 2.  To evaluate the effectiveness of 2-week home-based chronic non-invasive transcranial brain stimulation (NIBS) in…
  • 2022 International Congress

    Utilisation of the Clinical Frailty Scale to prompt transfer of patients with Parkinson’s disease from Neurology to Geriatric Medicine services.

    A. Thomson, T. Jones, C. Chan, C. Miller (Salford, United Kingdom)

    Objective: The aim of this study was to determine the feasibility of the Clinical Frailty Scale (CFS) as a tool to trigger clinicians' transfer of…
  • 2022 International Congress

    Cortical beta activity in doorway-provoked motor blocks in Parkinson’s disease

    S. Tran, J. Baarbe, R. Chen (Toronto, Canada)

    Objective: To investigate cortical activity of doorway-provoked motor blocks (MB) during pedalling in Parkinson’s disease (PD). Background: Freezing of gait (FOG) is common in PD…
  • « Previous Page
  • 1
  • …
  • 627
  • 628
  • 629
  • 630
  • 631
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley